167 related articles for article (PubMed ID: 3118122)
1. Different antagonist binding properties of rat pancreatic and cardiac muscarinic receptors.
Waelbroeck M; Camus J; Winand J; Christophe J
Life Sci; 1987 Nov; 41(19):2235-40. PubMed ID: 3118122
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of muscarinic receptors in neonatal rat cardiomyocytes.
Yang CM; Chen FF; Sung TC; Hsu HF; Wu D
Am J Physiol; 1993 Sep; 265(3 Pt 1):C666-73. PubMed ID: 8214023
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
4. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
5. A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini.
Korc M; Ackerman MS; Roeske WR
J Pharmacol Exp Ther; 1987 Jan; 240(1):118-22. PubMed ID: 2433426
[TBL] [Abstract][Full Text] [Related]
6. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.
Delmendo RE; Michel AD; Whiting RL
Br J Pharmacol; 1989 Feb; 96(2):457-64. PubMed ID: 2924085
[TBL] [Abstract][Full Text] [Related]
7. Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes.
Liebmann C; Nawrath S; Schnittler M; Schubert H; Jakobs KH
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):7-15. PubMed ID: 1538792
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
Waelbroeck M; Gillard M; Robberecht P; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):91-9. PubMed ID: 3600616
[TBL] [Abstract][Full Text] [Related]
9. Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.
Giraldo E; Viganò MA; Hammer R; Ladinsky H
Mol Pharmacol; 1988 Jun; 33(6):617-25. PubMed ID: 3380078
[TBL] [Abstract][Full Text] [Related]
10. [3H]N-methylscopolamine binding studies reveal M2 and M3 muscarinic receptor subtypes on cerebellar granule cells in primary culture.
Alonso R; Didier M; Soubrie P
J Neurochem; 1990 Jul; 55(1):334-7. PubMed ID: 2355226
[TBL] [Abstract][Full Text] [Related]
11. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
Smith TD; Annis SJ; Ehlert FJ; Leslie FM
J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptor subtypes on rat pancreatic acini: secretion and binding studies.
Louie DS; Owyang C
Am J Physiol; 1986 Aug; 251(2 Pt 1):G275-9. PubMed ID: 2426974
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic M1, M2 receptor binding. Relationship with functional efficacy.
Freedman SB; Beer MS; Harley EA
Eur J Pharmacol; 1988 Oct; 156(1):133-42. PubMed ID: 3208836
[TBL] [Abstract][Full Text] [Related]
14. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
15. M1 and M3 muscarinic receptor subtypes in rat forebrain.
Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
[TBL] [Abstract][Full Text] [Related]
16. Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes.
Waelbroeck M; Camus J; Tastenoy M; Christophe J
Br J Pharmacol; 1992 Jan; 105(1):97-102. PubMed ID: 1596694
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic responses of gastric parietal cells.
Wilkes JM; Kajimura M; Scott DR; Hersey SJ; Sachs G
J Membr Biol; 1991 Jun; 122(2):97-110. PubMed ID: 1895339
[TBL] [Abstract][Full Text] [Related]
18. Molecular probes for muscarinic receptors: derivatives of the M1-antagonist telenzepine.
Karton Y; Baumgold J; Handen JS; Jacobson KA
Bioconjug Chem; 1992; 3(3):234-40. PubMed ID: 1520727
[TBL] [Abstract][Full Text] [Related]
19. M3 muscarinic acetylcholine receptor coupling to PLC in rat exorbital lacrimal acinar cells.
Mauduit P; Jammes H; Rossignol B
Am J Physiol; 1993 Jun; 264(6 Pt 1):C1550-60. PubMed ID: 8333505
[TBL] [Abstract][Full Text] [Related]
20. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.
Waelbroeck M; Gillard M; Robberecht P; Christophe J
Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
